Ciliary body medulloepithelioma: Analysis of 41 cases

dc.contributor.author Kaliki, Swathi
dc.contributor.author Shields, Carol L.
dc.contributor.author Eagle, Ralph C.
dc.contributor.author Vemuganti, Geeta K.
dc.contributor.author Almeida, Ana
dc.contributor.author Manjandavida, Fairooz P.
dc.contributor.author Mulay, Kaustubh
dc.contributor.author Honavar, Santosh G.
dc.contributor.author Shields, Jerry A.
dc.date.accessioned 2022-03-27T04:11:42Z
dc.date.available 2022-03-27T04:11:42Z
dc.date.issued 2013-12-01
dc.description.abstract Purpose: To describe the clinical features, histopathology, treatment, and outcomes of ciliary body medulloepithelioma. Design: Retrospective study. Participants: Forty-one patients with medulloepithelioma. Intervention: Cryotherapy, plaque radiotherapy, external beam radiotherapy, tumor removal by partial lamellar sclerouvectomy (PLSU), or enucleation. Main Outcome Measures: Metastasis and death. Results: Of 41 patients with ciliary body medulloepithelioma, the median age at diagnosis was 5 years. The mean tumor basal diameter was 11 mm, and the mean tumor thickness was 7 mm. Related features included secondary glaucoma (n = 18, 44%), iris neovascularization (n = 21, 51%), cataract (n = 19, 46%), lens subluxation (n = 11, 27%), lens coloboma (n = 8, 20%), retrolental neoplastic cyclitic membrane (n = 21, 51%), intratumoral cysts (n = 25, 61%), and extraocular extension (n = 4, 10%). There was systemic association with pleuropulmonary blastoma in 2 cases (5%). Primary tumor treatment included enucleation (n = 21, 60%), tumor removal by PLSU (n = 8, 23%), plaque radiotherapy (n = 3, 9%), external beam radiotherapy (n = 1, 3%), cryotherapy (n = 1, 3%), or palliative chemotherapy (n = 1, 3%). In 1 case, medulloepithelioma was diagnosed histopathologically after inadvertent evisceration for blind painful eye. Subsequent treatment for residual or recurrent tumor in cases treated conservatively/inappropriately (n = 15) was necessary in 7 cases (47%). Histopathology disclosed benign features in 6 cases (20%), malignant features in 24 cases (80%), teratoid features in 11 cases (37%), and nonteratoid features in 19 cases (63%). In the 26 enucleated eyes, other features included retrolental neoplastic cyclitic membrane (n = 18, 69%), neoplastic epiretinal membrane (n = 6, 23%), and persistent hyaloid artery (n = 6, 23%). Systemic metastasis occurred in 3 cases (8%) over a mean follow-up of 49 months, all of whom presented with extrascleral extension of tumor due to mean delay in diagnosis by 39 months. Conclusions: Medulloepithelioma most commonly occurs in children. Systemic association with pleuropulmonary blastoma rarely is found. Patients with extrascleral medulloepithelioma are at risk for metastasis. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article. © 2013 by the American Academy of Ophthalmology Published by Elsevier Inc.
dc.identifier.citation Ophthalmology. v.120(12)
dc.identifier.issn 01616420
dc.identifier.uri 10.1016/j.ophtha.2013.05.015
dc.identifier.uri https://www.sciencedirect.com/science/article/abs/pii/S0161642013004417
dc.identifier.uri https://dspace.uohyd.ac.in/handle/1/6797
dc.title Ciliary body medulloepithelioma: Analysis of 41 cases
dc.type Journal. Article
dspace.entity.type
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: